Regeneron Pharmaceuticals, Inc.
ISIN US75886F1075
|WKN 881535
Market cap (in EUR)
55.533,68 m
Country
Estados Unidos
Sector
Salud
Dividend yield
0,15%
Overview
Quote
Trade with your broker
Description
Regeneron Pharmaceuticals, Inc. es una empresa de biotecnología que se dedica al descubrimiento, invención, desarrollo, fabricación y comercialización de medicamentos. Su cartera de productos incluye las siguientes marcas Dupixent, Evkeeza, Eylea, Inmazeb y Kevzara. La empresa acelera el proceso tradicional de desarrollo de fármacos mediante sus tecnologías VelociSuite patentadas, como VelocImmune, que utiliza ratones genéticamente humanizados únicos para producir anticuerpos y anticuerpos biespecíficos optimizados totalmente humanos. La empresa fue fundada por Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos y Eric M. Shooter el 8 de enero de 1988, y tiene su sede en Tarrytown, Nueva York.
Salud Biofarmacéuticos Productos biofarmacéuticos específicos del sistema Estados Unidos
Financials
Key metrics
| Market capitalisation, EUR | 55.533,68 m |
| EPS, EUR | 36,59 |
| P/B ratio | 2,11 |
| P/E ratio | 14,62 |
| Dividend yield | 0,15% |
Gewinn- und Verlustrechnung (2024)
| Revenue, EUR | 13.129,39 m |
| Net income, EUR | 4.079,34 m |
| Profit margin | 31,07% |
In welchen ETFs ist Regeneron Pharmaceuticals, Inc. enthalten?
There are 374 ETFs which contain Regeneron Pharmaceuticals, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Regeneron Pharmaceuticals, Inc. is the VanEck Genomics and Healthcare Innovators UCITS ETF A.
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Select your savings amount:
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
 | 0.00€ | 0.00€ | View offer* | |
 | 0.00€ | 0.00€ | View offer* | |
 | 0.00€ | 0.00€ | View offer* | |
 | 0.00€ | 0.00€ | View offer* | |
 | 0.00€ | 0.00€ | View offer* |
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
Performance
Returns overview
| YTD | -24.26% |
| 1 month | +1.81% |
| 3 months | -20.32% |
| 6 months | -31.21% |
| 1 year | -43.83% |
| 3 years | -17.68% |
| 5 years | -2.81% |
| Since inception (MAX) | +38.48% |
| 2024 | -15.31% |
| 2023 | +18.11% |
| 2022 | +17.80% |
| 2021 | +45.43% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 32.05% |
| Volatility 3 years | 29.64% |
| Volatility 5 years | 28.97% |
| Return per risk 1 year | -1.37 |
| Return per risk 3 years | -0.21 |
| Return per risk 5 years | -0.02 |
| Maximum drawdown 1 year | -56.57% |
| Maximum drawdown 3 years | -56.57% |
| Maximum drawdown 5 years | -56.57% |
| Maximum drawdown since inception | -56.57% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
